Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 1.00 |
| ▸ | ATM | Q13315 | 1/20 | 0.70 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | NAAA | Q02083 | 1/20 | 0.52 |
| ▸ | APP | P05067 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | PRKCA | P17252 | 2/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL992844 | 1.00 | HCAR2 (1.00) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL1013504 | 1.00 | HCAR2 (1.00) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL1578771 | 1.00 | HCAR2 (1.00) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL1400164 | 1.00 | HCAR2 (1.00) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL1578510 | 1.00 | HCAR2 (1.00) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL1250940 | 1.00 | HCAR2 (1.00) | HCAR2ATMMAPTRAB9ANPSR1 | |
| Decane SCHEMBL2831201 | 1.00 | HCAR2 (1.00) | HCAR2ATMMAPTRAB9ANPSR1 | |
| Stearyl Fumaric Acid SCHEMBL295874 | 1.00 | HCAR2 (1.00) | HCAR2ATMMAPTRAB9ANPSR1 | |
| Hexyl Fumarate SCHEMBL981512 | 1.00 | HCAR2 (1.00) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL809365 | 1.00 | HCAR2 (1.00) | HCAR2ATMMAPTRAB9ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3162 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075414-A | Tegordonin solid dispersion, preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-20260115142-A1 | PHARMACEUTICAL COMPOSITION COMPRISING ROSUVASTATIN AND ACETYLSALICYLIC ACID, PROCESS FOR PREPARING THE SAME, AND USES THEREOF | LABORATORIOS SILANES S A DE C V (MX) | 2026-04-30 | — | — | US | claimed |
| US-20260108525-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TICAGRELOR AND ACETYLSALICYLIC ACID, PROCESS FOR PREPARING THE SAME, AND USES THEREOF | LABORATORIOS SILANES S A DE C V (MX) | 2026-04-23 | — | — | US | claimed |
| EP-4729050-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TICAGRELOR AND ACETYLSALICYLIC ACID, AND PROCESS FOR PREPARING THE SAME | Laboratorios Silanes, S.A. de C.V. (MX) | 2026-04-22 | — | — | EP | claimed |
| EP-4717256-A1 | PHARMACEUTICAL COMPOSITION COMPRISING ROSUVASTATIN AND OMEGA-3, PROCESS FOR PREPARING THE SAME, AND USES THEREOF | Laboratorios Silanes, S.A. de C.V. (MX) | 2026-04-01 | — | — | EP | claimed |
| US-20260060930-A1 | New crystalline Forms, new pharmaceutical Composition and Dose Regimen of a Dipeptidyl peptidase I inhibitor for the Treatment of Patients with Bronchiectasis or other DPP-I mediated Diseases | BOEHRINGER INGELHEIM INT (DE) | 2026-03-05 | — | — | US | claimed |
| WO-2026046911-A1 | A DIPEPTIDYL-PEPTIDASE I INHIBITOR FOR ITS USE IN THE TREATMENT OF ANCA-ASSOCIATED VASCULITIS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2026-03-05 | — | — | WO | claimed |
| EP-4637772-A1 | DOSING SCHEDULE OF A SOLID DISPERSION OF A HER2 INHIBITOR | Boehringer Ingelheim International GmbH (DE) | 2025-10-29 | — | — | EP | claimed |
| EP-4637771-A1 | SOLID DISPERSION OF A HER2 INHIBITOR | Boehringer Ingelheim International GmbH (DE) | 2025-10-29 | — | — | EP | claimed |
| EP-4606374-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AZILSARTAN MEDOXOMIL POTASSIUM AND CALCIUM CHANNEL BLOCKER, METHOD FOR PREPARING SAME, AND USE THEREOF | Shanghai Aurora Biotechnology Co., Ltd. (CN) | 2025-08-27 | — | — | EP | claimed |
| CN-1101187-C | Fluoxetine pharmaceutical formulations | LILLY SA (ES) | 2003-02-12 | — | — | CN | claimed |
| CN-1310999-A | Low-dose entecavir preparation and application thereof | BRISTOL MYERS SQUIBB CO (US) | 2001-09-05 | — | — | CN | claimed |
| CN-1284866-A | Oral pharmaceutical extended release dosage form | ASTRA ZENECA AKTIEBOLAG (SE) | 2001-02-21 | — | — | CN | claimed |
| CN-1225580-A | Potassium, sodium and tris oxaprozin salt pharmaceutical formulations | G D SEARLER & CO (US) | 1999-08-11 | — | — | CN | claimed |
| US-5762951-A | ANALGESICS, ANTACIDS | BAYER AKTIENGESELLSCHAFT (DE) | 1998-06-09 | — | — | US | claimed |
| CN-1123142-A | Fluoxetine pharmaceutical formulations | LILLY SA (ES) | 1996-05-29 | — | — | CN | claimed |
| EP-0381414-B1 | Anti-ulcer composition | SQUIBB & SONS INC (US) | 1994-06-22 | — | — | EP | claimed |
| EP-0408273-B1 | Fosinopril tablet formulations | SQUIBB & SONS INC (US) | 1994-01-19 | — | — | EP | claimed |
| EP-0012499-B1 | DRY POWDERED NON-DAIRY FOOD COMPOSITION CONTAINING LIQUID FAT | R.G.B. LABORATORIES, INC. (US) | 1984-03-07 | — | — | EP | claimed |
| US-3943264-A | Whey product | KRAFTCO CORPORATION (US) | 1976-03-09 | — | — | US | claimed |